ANALYSIS OF MUTATIONS AT POSITION-184 IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引：97

作者：

BOYER, PL ^{[1
]}

HUGHES, SH ^{[1
]}

机构：

[1] NCI,FREDERICK CANC RES & DEV CTR,BASIC RES PROGRAM,ADV BIOSCI LABS,FREDERICK,MD 21702

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1995年 / 39卷 / 07期

关键词：

D O I：

10.1128/AAC.39.7.1624

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We have analyzed recombinant human immunodeficiency virus type I reverse transcriptases that contain mutations at position 184. These variants retain high levels of RNA-dependent DNA polymerase activity and show resistance to ddITP. However, the mutants varied in their ability to polymerize processively. The variants Met184Ile and Met184Val showed slight reductions in processivity relative to that of the wild-type enzyme; the variants Metl84Ala and Met184Leu showed considerable reductions in their processivity.

引用

页码：1624 / 1628

页数：5

共 42 条

[31] IDENTIFICATION OF 4 CONSERVED MOTIFS AMONG THE RNA-DEPENDENT POLYMERASE ENCODING ELEMENTS [J].

POCH, O ;

SAUVAGET, I ;

DELARUE, M ;

TORDO, N .

EMBO JOURNAL, 1989, 8 (12) :3867-3874

[32] RESISTANCE OF CLINICAL ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TO ANTIRETROVIRAL AGENTS [J].

RICHMAN, DD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1207-1213

[33] CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUSES RESISTANT TO OXATHIOLANE-CYTOSINE NUCLEOSIDES [J].

SCHINAZI, RF ;

LLOYD, RM ;

NGUYEN, MH ;

CANNON, DL ;

MCMILLAN, A ;

ILKSOY, N ;

CHU, CK ;

LIOTTA, DC ;

BAZMI, HZ ;

MELLORS, JW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) :875-881

[34] RESISTANCE TO DDI AND SENSITIVITY TO AZT INDUCED BY A MUTATION IN HIV-1 REVERSE-TRANSCRIPTASE [J].

STCLAIR, MH ;

MARTIN, JL ;

TUDORWILLIAMS, G ;

BACH, MC ;

VAVRO, CL ;

KING, DM ;

KELLAM, P ;

KEMP, SD ;

LARDER, BA .

SCIENCE, 1991, 253 (5027) :1557-1559

[35] LOCATIONS OF ANTI-AIDS DRUG-BINDING SITES AND RESISTANCE MUTATIONS IN THE 3-DIMENSIONAL STRUCTURE OF HIV-1 REVERSE-TRANSCRIPTASE - IMPLICATIONS FOR MECHANISMS OF DRUG-INHIBITION AND RESISTANCE [J].

TANTILLO, C ;

DING, JP ;

JACOBOMOLINA, A ;

NANNI, RG ;

BOYER, PL ;

HUGHES, SH ;

PAUWELS, R ;

ANDRIES, K ;

JANSSEN, PAJ ;

ARNOLD, E .

JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (03) :369-387

[36] RAPID INVITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-THIACYTIDINE INHIBITORS DUE TO A MUTATION IN THE YMDD REGION OF REVERSE-TRANSCRIPTASE [J].

TISDALE, M ;

KEMP, SD ;

PARRY, NR ;

LARDER, BA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5653-5656

[37]

VARMUS HE, 1988, SCIENCE, V240, P142

[38] CHARACTERIZATION OF HIGHLY IMMUNOGENIC P66 P51 AS THE REVERSE-TRANSCRIPTASE OF HTLV-III LAV [J].

VERONESE, FD ;

COPELAND, TD ;

DEVICO, AL ;

RAHMAN, R ;

OROSZLAN, S ;

GALLO, RC ;

SARNGADHARAN, MG .

SCIENCE, 1986, 231 (4743) :1289-1291

[39] INVITRO ENZYMATIC-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE MUTANTS IN THE HIGHLY CONSERVED YMDD AMINO-ACID MOTIF CORRELATES WITH THE INFECTIOUS POTENTIAL OF THE PROVIRAL GENOME [J].

WAKEFIELD, JK ;

JABLONSKI, SA ;

MORROW, CD .

JOURNAL OF VIROLOGY, 1992, 66 (11) :6806-6812

[40]

WEISS R, 1985, MOL BIOL TUMOR VIRUS, V2

← 1 2 3 4 5 →